• News
  • Investment
  • Lifestyle
  • Videos

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy

Investment

  • Investment portal
  • Investment portal login
  • Register as an investor
  • Raise finance

Lifestyle

  • Home
  • Supplements
  • Self-testing
  • Exercise
  • Nutrition
  • Tech
  • Mental wellness
  • Product reviews

More

  • Contact
  • Features

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy
Posted on July 23, 2021December 9, 2022

Longevity senotherapeutics report: Insilico Medicine

Insilico – on a mission to accelerate senescence drug discovery and development by continuously inventing and deploying new AI technologies. …

Continue reading “Longevity senotherapeutics report: Insilico Medicine”

Posted on July 21, 2021December 12, 2022

Longevity senotherapeutics report: Cleara Biotech

Cleara Biotech – on a mission to target cellular senescence to extend human healthspan at old age. Over the coming …

Continue reading “Longevity senotherapeutics report: Cleara Biotech”

Posted on July 19, 2021May 12, 2022

Longevity senotherapeutics report: TAmiRNA

Biomarkers for more stability in life – TAmiRNA is harnessing the power of microRNAs for the development of innovative diagnostic …

Continue reading “Longevity senotherapeutics report: TAmiRNA”

Posted on July 15, 2021May 12, 2022

Longevity senotherapeutics report: Atropos Therapeutics

Strong academic pedigree is crafting senescence’s fate from rigorous science – suppression. Over the coming weeks, we will be bringing …

Continue reading “Longevity senotherapeutics report: Atropos Therapeutics”

Posted on July 14, 2021February 7, 2023

Longevity senotherapeutics report: Rubedo Life Sciences

A unique synergy of proprietary technologies and expertise is advancing compounds from discovery to preclinical efficacy. Over the coming weeks, …

Continue reading “Longevity senotherapeutics report: Rubedo Life Sciences”

Posted on July 12, 2021May 12, 2022

Longevity senotherapeutics report: Oisín Biotechnologies

Leveraging technology and information to address the damage created by the aging process itself. Over the coming weeks, we will …

Continue reading “Longevity senotherapeutics report: Oisín Biotechnologies”

Posted on July 8, 2021May 12, 2022

Longevity senotherapeutics report: Rockfish Bio

Using senolytics to target a druggable pathway that plays a pivotal role in many age-related diseases. Over the coming weeks, …

Continue reading “Longevity senotherapeutics report: Rockfish Bio”

Find us here ...

Subscribe to our newsletter

Hidden

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy

Investment

  • Investment portal
  • Investment portal login
  • Register as an investor
  • Raise finance

Lifestyle

  • Home
  • Supplements
  • Self-testing
  • Exercise
  • Nutrition
  • Tech
  • Mental wellness
  • Product reviews

More

  • Contact
  • Features
  • Editorial Policy
  • Privacy Policy
  • Cookie Policy
  • Conditions of Business
  • Terms and Conditions
  • Copyright Policy
© Copyright 2022 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY
First Longevity Ltd is an appointed representative of Prospect Capital Ltd which is authorised and regulated by the Financial Conduct Authority.
The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding and knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.